Ketamine has ‘fast-acting benefits’ for depression

Latest news

    KetamineImage copyright Science Photo Library

    Ketamine has “shown promise” in the rapid treatment of major depression and suicidal thoughts, a US study says.

    Ketamine has a reputation as a party drug but is licensed as an anaesthetic.

    The study found use of the drug via a nasal spray led to “significant” improvements in depressive symptoms in the first 24 hours.

    The Royal College of Psychiatrists said it was a “significant” study that brought the drug “a step closer to being prescribed on the NHS”.

    The report by researchers from Janssen Research and Development, a Johnson and Johnson company, and Yale School of Medicine, is the first study into ketamine as a treatment for depression that has been done by a drug company.

    It is being published in the American Journal of Psychiatry.

    The trial looked at 68 people at imminent risk of suicide.

    All patients were treated with a stay in hospital and anti-depressants.

    In addition, half were given ketamine in the form of esketamine (part of the ketamine molecule) in a nasal spray and half were given a placebo.

    The study found those using esketamine had a much greater improvement in depression symptoms at all points over the first four weeks of treatment.

    However, at 25 days the effects had levelled out.

    The study’s authors suggest it could offer an effective rapid treatment for people severely depressed and at imminent risk of suicide and could help in the initial stages of treatment, as most anti-depressants take four to six weeks to become fully effective.

    The nasal spray is now undergoing phase three trials before it can be licensed for treatment.

    Potential for abuse

    There were no reports of esketamine dependence or misuse in the trial but the authors warn that more research is needed on the potential for abuse of ketamine and say these should be looked at during subsequent trials.

    Scientists in the UK are also studying ketamine as a treatment for depression taken intravenously.

    Dr James Stone, from the Royal College of Psychiatrists, said the “interesting” US study confirmed the findings from successful studies into intravenous ketamine.

    “The main reason for its significance is because this is being developed by a drug company and it’s potentially quite likely that this medication might become available as a treatment available on the NHS for depression.”

    ‘Severe depression’

    He said because it was being given as a nasal spray it was “much easier to administer” than intravenous ketamine and was “potentially quicker to give, so it means more people can be dosed at the same time” and you need less equipment.

    Dr Stone said if it did go on to be prescribed on the NHS it would be aimed at people with severe depression as a second or third line of treatment if other drugs haven’t worked and could be used for people instead of electroconvulsive therapy.

    Prof Mitul Mehta from King’s College said it was an “exciting” study.

    “All the studies to date have been looking at intravenous use – there are some people who have explored oral ketamine but that doesn’t appear to be as successful as intravenous so intranasal seems to be a really good halfway-house.

    “It enters the body relatively quickly – it’s not as fast as going straight into your bloodstream but not as slow as via the stomach and it’s reasonably easy to control how much you give to a person. In that respect this is a really important study.”

    But he said far bigger studies are needed to look out for any rare side-effects.

    Prescribed off licence

    Because ketamine is licensed to be used by doctors as an aneasthetic it can be prescribed off licence for depression. This is happening in private clinics in the US and the UK.

    But to be prescribed on the NHS, it would need to be licensed to be used as a treatment for depression.

    In the UK, doctors have been trialling ketamine to treat depression since 2011.

    Dr Rupert McShane, who has led a trial in Oxford, says ketamine can work on patients with depression “where nothing has helped before”.

    Last year he called for the use of ketamine to treat depression to be rolled out.

    However, he called for a national registry to monitor its use.

    View the original article: http://www.bbc.co.uk/news/health-43753073

    http://www.bbc.co.uk/news/health-43753073

    In the same category are

    Grenfell fire: Ban on combustible material ‘not enough’ Image copyright PA Image caption The cladding used on Grenfell Tower in west London meant the fire spread quickly The government's proposed ban on...
    BMX fan in Nigeria overjoyed by bike sent in post When Cherechukwu Udenkwere received a parcel at his home in Nigeria, he was overjoyed at the contents.Inside was a brand new BMX bike for the 20-year-...
    Could a prime minister ever have a Brummie accent? Image copyright PA Image caption Jess Phillips wants the way the Commons sounds to change Accents show a lot about a person's life and background....
    The story of how one compilation came to rule them all Image caption Three Now albums have been released every year since 1983 Now That's What I Call Music is the biggest-selling compilation series in ...
    County Cricket: The ‘Take That’ influence and how the ‘Hundred’ could change game Lancashire's Emirates Old Trafford home ground has hosted music concerts for more than two decades, with bands and artists such as Take That, Beyonce...

    Leave a comment

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.